Delivery Order SPE2DB22D1106-SPE2DB24FETZ9
Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $35K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,339.68 Firm Fixed Price Delivery Order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This is a $11,150.93 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 500S. The contract has an ultimate completion date of June 30, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This federal contract award, with a GovTribe ID of SPE2DB22D3301|SPE2DB25FY4MW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,181.66 firm fixed-price delivery order is for the supply of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product. The award has an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,406.80, is for the delivery of CELLCEPT 500 MG TABLET 500S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a completion date of June 10, 2025. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors listed. The company holds a...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $25,351.33, is for the delivery of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product, with a period of performance through August 6, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts and...
- This federal contract award, valued at $21,787.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the supply of CellCept 500 mg tablets, a medication used to prevent organ rejection in transplant patients....
- This federal contract award, with ID SPE2DX15D1022|SPE2DX25FVCYT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $16,395.56 firm fixed-price delivery order is for the supply of 4567495019 CELLCEPT 500 MG TABLET 500S. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,308.08 Firm Fixed Price Delivery Order contract is for the supply of 4567331014 - MYCOPHENOLATE 500 MG TABLET 500S, with a completion date of February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,364.70 firm fixed-price delivery order is for Mycophenolate 500 mg tablets, a specialty medication. The contract has a ceiling value of $1,364.70 and an ultimate completion date of February 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that...
- The Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on April 23, 2025, valued at $7,818.08 for 100 tablets of CellCept 500 mg, with final delivery due by April 24, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The vendor, headquartered in Conshohocken,...